| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Dermot M F Cooper | |
| Tasmina A Goraya | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 789-97 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Cellular Signalling | Q1524097 |
| P1476 | title | Ca2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives | |
| P478 | volume | 17 |
| Q90271846 | A predictive computational model reveals that GIV/girdin serves as a tunable valve for EGFR-stimulated cyclic AMP signals |
| Q64952060 | A simple, robust, universal assay for real-time enzyme monitoring by signalling changes in nucleoside phosphate anion concentration using a europium(iii)-based anion receptor. |
| Q35204504 | Anti-epileptic effect of Ganoderma lucidum polysaccharides by inhibition of intracellular calcium accumulation and stimulation of expression of CaMKII α in epileptic hippocampal neurons |
| Q64892325 | Arginase II activity regulates cytosolic Ca2+ level in a p32-dependent manner that contributes to Ca2+-dependent vasoconstriction in native low-density lipoprotein-stimulated vascular smooth muscle cells. |
| Q37211818 | BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function. |
| Q36093228 | Bursting and calcium oscillations in pancreatic beta-cells: specific pacemakers for specific mechanisms. |
| Q42416262 | Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle |
| Q37422056 | Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells |
| Q36454170 | Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells |
| Q37657841 | Clinical and molecular genetics of the phosphodiesterases (PDEs). |
| Q27648887 | Conformational Variations of Both Phosphodiesterase-5 and Inhibitors Provide the Structural Basis for the Physiological Effects of Vardenafil and Sildenafil |
| Q28392899 | Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking |
| Q36334968 | Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies |
| Q37051278 | Cyclic nucleotide signaling in polycystic kidney disease |
| Q37128615 | Deciphering and modulating G protein signalling in C. elegans using the DREADD technology |
| Q42487697 | Direct action of capsaicin in brown adipogenesis and activation of brown adipocytes |
| Q54342578 | Effects of cisplatin on lymphocyte structure and functions in mice with ehrlich ascitic carcinoma. |
| Q36855547 | Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase |
| Q41153428 | Generation and phenotypic characterization of Pde1a mutant mice. |
| Q44327186 | Importance of the interaction protein-protein of the CaM-PDE1A and CaM-MLCK complexes in the development of new anti-CaM drugs. |
| Q50627316 | In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors. |
| Q52676144 | Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease. |
| Q36754707 | Modelling intracellular competition for calcium: kinetic and thermodynamic control of different molecular modes of signal decoding |
| Q36849194 | Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies |
| Q36432214 | Monitoring of cAMP synthesis and degradation in living cells |
| Q60950131 | Mouse Cardiac Pde1C Is a Direct Transcriptional Target of Pparα |
| Q37977185 | Organization of cAMP signalling microdomains for optimal regulation by Ca2+ entry |
| Q42515895 | Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction. |
| Q64241539 | Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus |
| Q24336559 | Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP |
| Q28394978 | Phosphodiesterase regulation of alcohol drinking in rodents |
| Q33982175 | Polarized axonal surface expression of neuronal KCNQ potassium channels is regulated by calmodulin interaction with KCNQ2 subunit. |
| Q45958192 | Real-time monitoring of cAMP levels in living endothelial cells: thrombin transiently inhibits adenylyl cyclase 6. |
| Q38190300 | Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. |
| Q92815813 | Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells |
| Q35687974 | Regulatory Action of Calcium Ion on Cyclic AMP-Enhanced Expression of Implantation-Related Factors in Human Endometrial Cells |
| Q47732711 | Role of Phosphodiesterases in Huntington's Disease |
| Q52809588 | Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System. |
| Q39872689 | Store-operated cyclic AMP signalling mediated by STIM1. |
| Q82362862 | Temporally resolved cAMP monitoring in endothelial cells uncovers a thrombin-induced [cAMP] elevation mediated via the Ca²+-dependent production of prostacyclin |
| Q38064838 | The cyclic AMP pathway |
| Q50944400 | The regulatory 1α subunit of protein kinase A modulates renal cystogenesis. |
| Q33589110 | The role of calcium in the regulation of renin secretion |
| Q92461195 | Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond |
| Q41903612 | Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions. |
Search more.